基础医学与临床 ›› 2018, Vol. 38 ›› Issue (6): 745-750.

• 研究论文 •    下一篇

NO供体V-PYRRO/NO抑制大鼠肝脏I/R损伤早期LTC4S基因表达

苏湾英1,贺长生2,魏志萍1,邵亚兰1,杨美雯3,洪芬芳4,杨树龙5   

  1. 1. 井冈山市检验检测中心
    2. 南昌大学基础医学院
    3. 南昌大学抚州医学院
    4. 南昌大学医学院
    5. 南昌大学
  • 收稿日期:2017-04-24 修回日期:2017-07-03 出版日期:2018-06-05 发布日期:2018-05-25
  • 通讯作者: 杨树龙 E-mail:slyang@ncu.edu.cn
  • 基金资助:
    国家自然科学基金项目;国家自然科学基金项目;国家自然科学基金项目;江西省重点研发计划项目

NO donor V-PYRRO/NO inhibits expression of leukotriene C4 synthase in early stage of hepatic ischemia/reperfusion injury in rats

  • Received:2017-04-24 Revised:2017-07-03 Online:2018-06-05 Published:2018-05-25
  • Contact: Shulong Yang E-mail:slyang@ncu.edu.cn

摘要: 目的:探讨肝脏特异性NO供体V-PYRRO/NO对肝脏缺血再灌注(ischemia reperfushion, I/R)早期白三烯C4合酶(leukotriene C4 synthase, LTC4S)基因表达的作用机理。方法:将大鼠随机均分为假手术组(Sham),缺血再灌注组(I/R)(70%左右肝脏缺血60min再灌注5h模型)和V-PYRRO/NO +缺血再灌注组(V-PYRRO/NO)(经静脉给予V-PYRRO/NO (1.06 ?mol/kg?h))。用RT-PCR法检测肝脏组织LTC4S mRNA的表达,Western blot法检测肝细胞胞浆和核提取物中NF-κB p65, p50 and IκB蛋白表达。结果:I/R组肝脏组织中LTC4S mRNA的表达显著高于假手术组(P<0.05),而V-PYRRO/NO 干预组LTC4S mRNA的表达则明显降低(P<0.05);与假手术组相比,I/R组肝细胞核提取物中NF-κBp65 and p50蛋白表达上调(P<0.01),而胞浆中的相关蛋白则明显下调(P<0.01);V-PYRRO/NO组则完全逆转了I/R期间肝细胞核提取物中NF-κBp65 and p50蛋白表达增强(P<0.05),以及胞浆中的相关蛋白降低(P<0.01, P<0.05)。但各实验组IκB蛋白的表达无显著差异。正常大鼠肝脏中,胞质和胞核内NF-κBp65几乎不着色 ;I/R组肝细胞胞质和核中NF-κB p65表达强阳性,但V-PYRRO/NO I/R组肝细胞胞质和核中NF-κB p65阳性反应明显减弱。结论:在大鼠肝脏I/R损伤早期,V-PYRRO/NO下调了LTC4S mRNA的表达,其机制可能涉及抑制不依赖于IκB降解的NF-κB信号转导途径。

关键词: NO供体, NF-kB, 白三烯C4合酶, 缺血再灌注损伤, 肝脏

Abstract: Objectives: To explore the mechanism underlying a selective liver nitric oxide donor V-PYRRO/NO effects on the gene expression of LTC4 synthase (LTC4S) during hepatic I/R. Methods: Adult male SD rats were divided into 3 groups: control group (Sham), ischemic-reperfusion group(I/R) and V-PYRRO/NO groups. Liver subjected to 1h of partial hepatic ischemia followed by 5 h of reperfusion, saline or V-PYRRO/NO(1.06mmol/kg/h) administered intravenously. The mRNA expressions of LTC4S in rat liver tissue were examined by RT-PCR method, the protein expressions of NF-κB p65, p50 and IκB? in liver cell lysates and nuclear extracts were detected by western blot analysis. Results: hepatic mRNA expression of LTC4S in I /R group was higher (P<0.05) than that in sham group whereas it was lower in V-PYRRO/NO group than that in I /R group (P<0.05). Moreover, compare with sham group, the protein expressions of NF-κBp65 and p50 in nucleus extract were markedly increased(P<0.01) but significantly decreased in cytoplasm(P<0.01) in I/R group. V-PYRRO/NO reversed completely the increase of these protein expressions in nucleus extract (P<0.05) and the decrease of them in cytoplasm (P<0.01, P<0.05) during hepatic I/R injury. However, IκB? protein in three groups not changed. Immunohistochemistry staining revealed that no marked positive staining for NF-κB p65 was presented in sham liver, I/R liver exhibited strong cytoplasmic and nuclear positive staining for NF-κB p65, but V-PYRRO/NO I/R group liver presented slight cytoplasmic and nuclear staining. Conclusions: V-PYRRO/NO might down-regulated LTC4S mRNA expression by inhibiting NF-κB activation independent of IκB? during hepatic I/R injury.

Key words: NO donor, NF-kB, Leukotriene C4 synthase, Ischemia reperfusion injury, Liver